from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3031/-

LFCtreatmentdescriptionclass of inhibitor

0.319

Amikacinug/mL Amikacintranslation

-1.004

Cap5-10ug/mL Capreomycintranslation

-0.733

Rox10-50 ug/mL Roxithromycintranslation

1.567

SM2-5 ug/mL Streptomycintranslation

-0.737

Tet5-10 ug/mL Tetracyclinetranslation

0.902

Rif0.2-5ug/mL Rifampicintranscription

0.211

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.903

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.413

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.205

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.156

Clofazimine10-13 ug/mL Clofaziminerespiration

0.154

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.080

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.911

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.731

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.014

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.748

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-2.617

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.547

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.725

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.192

KCN5-20 ug/mL Potassium cyaniderespiration

-0.574

NaN30.2-2 mM Sodium aziderespiration

-0.857

Nigericin50 uM Nigericinrespiration

-0.348

TRC10-150 ug/mL Triclosanrespiration

-0.740

TRZ10-25 ug/mL Thioridazinerespiration

0.047

Valinomycin0.5-10 uM Valinomycinrespiration

-0.957

ZnSO42 mM ZnSO4respiration

1.033

menadione6-10 ug/mL Menadionerespiration

0.720

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.722

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.640

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.005

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.333

NRP_1Non-replicating persistence stage 1dosRassociated

0.208

Amp0.2mg/mL AmpicillincellWall

0.465

Cephalexin20-100 ug/mL CephalexincellWall

0.341

Cerulenin0.32-5 ug/mL CerulenincellWall

0.666

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.341

EMB10-20 ug/mL EthambutolcellWall

0.092

Eta12-40 ug/mL EthionamidecellWall

0.761

INH0.2-0.4 ug/mL IsoniazidcellWall

0.508

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.219

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.444

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.555

BZA0.12 mg/mL BenzamidearomaticAmides

0.514

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.015

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.664

H2O24 mM hydrogen peroxideDNAdamaging

0.227

Levo10 ug/mL LevofloxacinDNAdamaging

0.288

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.871

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.424

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.243

UVUV-irradiationDNAdamaging

0.057

ARP41-4 ug/mL Antitubercular compound ARP4?

0.902

Antimycin12.5-50 ug/mL Antimycin A?

0.383

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.311

PA_110-50 ug/mL Antitubercular compound PA-1?

0.231

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.148

PA8240.2-2 ug/mL PA-824?

-0.328

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.262

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.316

Verapamil50 uM Verapamil?

1.240

mercaptoethanol2 mM 2-Mercaptoethanol?

0.717

methoxatin10-20 ug/mL Methoxatin?